Mobile Technology for Blood Pressure Management

Stanford University

Status: Completed

Conditions: Hypertension

Treatments: Combination Product: Mobile technology intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT04841317

59671

20FRN35360178 (Other Grant/Funding Number)

Details and patient eligibility

About

The primary objective of this study is to assess the feasibility and effectiveness of a mobile-technology based system that integrates patient-facing and clinician-facing components to assist the management of hypertension.

Enrollment: 31 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18 years or older with an established diagnosis of essential hypertension

Exclusion criteria

• Patients on more than 2 antihypertensives at time of enrollment
• Clinical diagnosis of secondary hypertension, that is, hypertension due to a secondary cause, including but not limited to the following:
• Renal artery stenosis
• Primary hyperaldosteronism
• Cushing syndrome
• Coarctation of the aorta
• Drug-induced hypertension
• Pheochromocytoma
• Obstructive sleep apnea
• Hospitalization for malignant hypertension or severe hypertension (including stroke, cardiac events, acute kidney injury) in the preceding 6 months
• Hospitalization for unstable angina or myocardial infarction in the preceding 6 months
• Prior diagnosis of heart failure or cardiomyopathy
• Stroke or transient ischemic attack within prior 6 months
• Prior organ transplantation
• Failure to obtain informed consent
• Pregnant or currently trying to become pregnant
• Patients who are enrolled in other research studies

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

31 participants in 1 patient group

Single-arm: Blood pressure intervention

Experimental group

Description:

Participants will use a mobile technology system comprising of a remote home blood pressure monitoring cuff and a mobile application integrated with a clinician-facing component to view and manage remote blood pressures. Participants will use this for 12 weeks, with assessment of blood pressure outcomes and anonymous surveys regarding the technology at 12 weeks.

Treatment:

Combination Product: Mobile technology intervention